-
The Impact of Inhaler Technique on the Health Outcomes and Cost Among Adults With Asthma and Chronic Obstructive Pulmonary Disease in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Landscape of Data Sources for Real-World Observational Studies: Focus on the French Context
Sep 9, 2025, 16:22 PM -
Differential HTA Recommendations for Continuous Glucose Monitors (CGMs): A Global Comparative Review of HTA Focus, Challenges, and Solutions
Sep 9, 2025, 16:22 PM -
Assessing Treatment Efficiency Indicated in Rare Diseases: Learning From the CEESP Has Economic Opinions
Sep 9, 2025, 16:22 PM -
Accelerating RTOR in Oncology: The AIM Model for Agile Trial Operations
Sep 9, 2025, 16:22 PM -
Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair, Proficient Mismatch Repair, and Intention-to-Treat Populations From the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Comparative Evaluation of Sequence-Encoding Strategies for Clustering Inhaled Therapy Pathways in COPD Patients Using Real-World Data
Sep 9, 2025, 16:22 PM -
Revisiting the Willingness-to-Pay Threshold in the Czech Republic: Integrating QALY Shortfall to Reflect Disease Severity and Unmet Medical Need
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema
Sep 9, 2025, 16:22 PM -
Prices And Reimbursement Conditions for Poly (ADP-RIBOSE) Polymerase Inhibitors (PARPi) Indicated for Ovarian Cancer in Spain
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Lebrikizumab vs. Alternative Biologics in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis in the UK
Sep 9, 2025, 16:22 PM -
The Next Frontier in HTA Reviewing the Integration of Artificial Intelligence and Discrete Event Simulation for Resource Modeling
Sep 9, 2025, 16:22 PM -
Scientific Outcome of ISPOR Conferences: An Analysis of 67,055 Abstracts Presented at 54 ISPOR Conferences Between 2002-2024
Sep 9, 2025, 16:22 PM -
The Association of Glucagon-Like Peptide-1 Receptor Agonists With Hepatopancreatobiliary Diseases in Individuals With Type 2 Diabetes Mellitus
Sep 9, 2025, 16:22 PM -
Enhancing Operational Efficiency: Time and Cost Savings of a Minimally Invasive Vascular Closure Device in Germany
Sep 9, 2025, 16:22 PM -
The Prevalence of COAs and DHTs for Studying Sleep Disorders in Clinical Trials
Sep 9, 2025, 16:22 PM -
Are Real-World Survival Outcomes in Metastatic Breast Cancer Transportable Between the US and Austria?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of Orphan Drugs in France: Key Insights from CEESP Reviews (2021-2024)
Sep 9, 2025, 16:22 PM -
A Conceptual Framework for Enhancing the Clinical Utility of a Generic Veterinary Health-Related Quality of Life (HRQoL) Tool Vetmetrica™ Through the Addition of a Disease-Specific Module
Sep 9, 2025, 16:22 PM -
First-Line Immunotherapies for Advanced Biliary Tract Cancer: A Systematic Review of Economic Studies
Sep 9, 2025, 16:22 PM
